Header Logo

Connection

Michael Horberg to Peptide Fragments

This is a "connection" page, showing publications Michael Horberg has written about Peptide Fragments.
Connection Strength

0.339
  1. Virologic outcomes of changing enfuvirtide to raltegravir in HIV-1 patients well controlled on an enfuvirtide based regimen: 24-week results of the CHEER study. J Acquir Immune Defic Syndr. 2009 Aug 01; 51(4):367-73.
    View in: PubMed
    Score: 0.339

© 2024 Kaiser Permanente